REFERENCES
- Halliwell B. Oxidative stress and cancer: have we moved forward? Biochem J 2007;401:1–11.
- Halliwell B. Free radicals and antioxidants - quo vadis? Trends Pharmacol Sci 2011;32:125–130.
- Valko M, Leibfritz D, Moncol J et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44–84.
- Deepa PR, Nalini V, Mallikarjuna K et al. Oxidative stress in retinoblastoma: correlations with clinicopathologic features and tumor invasiveness. Curr Eye Res 2009;34:1011–1018.
- Adithi M, Nalini V, Krishnakumar S. The role of nitric oxide synthases and nitrotyrosine in retinoblastoma. Cancer 2005;103:1701–1711.
- Ganguly A, Shields CL. Differential gene expression profile of retinoblastoma compared to normal retina. Mol Vis 2010;16:1292–1303.
- Chakraborty S, Khare S, Dorairaj SK et al. Identification of genes associated with tumorigenesis of retinoblastoma by microarray analysis. Genomics 2007;90:344–353.
- Kim JH, Kim JH, Cho CS et al. Differential roles of matrix metalloproteinase-9 and -2, depending on proliferation or differentiation of retinoblastoma cells. Invest Ophthalmol Vis Sci 2010;51:1783–1788.
- Krishnakumar S, Mohan A, Mallikarjuna K et al. EpCAM expression in retinoblastoma: a novel molecular target for therapy. Invest Ophthalmol Vis Sci 2004;45:4247–4250.
- Mallikarjuna K, Sundaram CS, Sharma Y et al. Comparative proteomic analysis of differentially expressed proteins in primary retinoblastoma tumors. Proteomics Clin Appl 2010;4:449–463.
- Vandhana S, Deepa PR, Jayanthi U et al. Clinico-pathological correlations of fatty acid synthase expression in retinoblastoma: an Indian cohort study. Exp Mol Pathol 2011;90:29–37.
- Anantharam V, Lehrmann E, Kanthasamy A et al. Microarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: relevance to oxidative damage in Parkinson’s disease. Neurochem Int 2007;50:834–847.
- Tandon VR, Sharma S, Mahajan A, Bardi GH. Oxidative stress: a novel strategy in cancer treatment. Obs & Gyanea 2005;7:1–3.
- Murphy MP, Holmgren A, Larsson NG et al. Unraveling the biological roles of reactive oxygen species. Cell Metab 2011;13:361–366.
- Morgan KT, Ni H, Brown HR et al. Application of cDNA microarray technology to in vitro toxicology and the selection of genes for a real-time RT-PCR-based screen for oxidative stress in Hep-G2 cells. Toxicol Pathol 2002;30:435–451.
- Davies KJ. The broad spectrum of responses to oxidants in proliferating cells: a new paradigm for oxidative stress. IUBMB Life 1999;48:41–47.
- Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 2000;279:L1005–L1028.
- Benhar M, Engelberg D, Levitzki A. ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep 2002;3:420–425.
- Valko M, Rhodes CJ, Moncol J et al. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006;160:1–40.
- Schäfer G, Cramer T, Suske G et al. Oxidative stress regulates vascular endothelial growth factor-A gene transcription through Sp1- and Sp3-dependent activation of two proximal GC-rich promoter elements. J Biol Chem 2003;278:8190–8198.
- Sakata K, Shigemasa K, Nagai N et al. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Int J Oncol 2000;17:673–681.
- Aragon-Martin JA, Ahnood D, Charteris DG et al. Role of ADAMTSL4 mutations in FBN1 mutation-negative ectopia lentis patients. Hum Mutat 2010;31:E1622–E1631.
- Apte SS. A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif (ADAMTS) superfamily: functions and mechanisms. J Biol Chem 2009;284:31493–31497.
- Lu X, Kambe F, Cao X et al. 3beta-Hydroxysteroid-delta24 reductase is a hydrogen peroxide scavenger, protecting cells from oxidative stress-induced apoptosis. Endocrinology 2008;149:3267–3273.
- Pridgeon JW, Olzmann JA, Chin LS et al. PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol 2007;5:e172.
- Kono N, Inoue T, Yoshida Y et al. Protection against oxidative stress-induced hepatic injury by intracellular type II platelet-activating factor acetylhydrolase by metabolism of oxidized phospholipids in vivo. J Biol Chem 2008;283:1628–1636.
- Neumann-Haefelin E, Qi W, Finkbeiner E et al. SHC-1/p52Shc targets the insulin/IGF-1 and JNK signaling pathways to modulate life span and stress response in C. elegans. Genes Dev 2008;22:2721–2735.
- Nakamura R, Kataoka H, Sato N et al. EPHA2/EFNA1 expression in human gastric cancer. Cancer Sci 2005;96:42–47.
- Dong Z, Liu Y, Lu S et al. Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer. Mol Endocrinol 2006;20:2315–2325.
- Mashima T, Seimiya H, Tsuruo T. De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br J Cancer 2009;100:1369–1372.
- Sekiya M, Hiraishi A, Touyama M et al. Oxidative stress induced lipid accumulation via SREBP1c activation in HepG2 cells. Biochem Biophys Res Commun 2008;375:602–607.
- Kase S, Parikh JG, Rao NA. Expression of alpha-crystallin in retinoblastoma. Arch Ophthalmol 2009;127:187–192.
- Martindale JL, Holbrook NJ. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 2002;192:1–15.
- Haqq C, Nosrati M, Sudilovsky D et al. The gene expression signatures of melanoma progression. Proc Natl Acad Sci USA 2005;102:6092–6097.
- Epping MT, Bernards R. A causal role for the human tumor antigen preferentially expressed antigen of melanoma in cancer. Cancer Res 2006;66:10639–10642.
- Yagüe E, Arance A, Kubitza L et al. Ability to acquire drug resistance arises early during the tumorigenesis process. Cancer Res 2007;67:1130–1137.
- Maher JM, Dieter MZ, Aleksunes LM et al. Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway. Hepatology 2007;46:1597–1610.
- Donkena KV, Young CY, Tindall DJ. Oxidative stress and DNA methylation in prostate cancer. Obstet Gynecol Int 2010;2010:302051.
- Kumar B, Koul S, Khandrika L et al. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res 2008;68:1777–1785.
- Conklin KA. Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integr Can Ther 2004;3:294–300.